| PERIOD ENDING | 31-Mar-09 | 31-Mar-08 | 31-Mar-07 | | Total Revenue | 218,367 | 166,733 | 153,186 | | Cost of Revenue | 125,402 | 106,983 | 86,647 | | | Gross Profit | 92,965 | 59,750 | 66,539 | | | Operating Expenses | | Research Development | 18,070 | 12,306 | 7,184 | | Selling General and Administrative | 32,871 | 26,221 | 27,136 | | Non Recurring |
-
|
-
|
-
| | Others |
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
| | | | Operating Income or Loss | 42,024 | 21,223 | 32,219 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 1,820 | 6,420 | 8,150 | | Earnings Before Interest And Taxes | 43,844 | 27,643 | 40,369 | | Interest Expense | 144 | 158 | 353 | | Income Before Tax | 43,700 | 27,485 | 40,016 | | Income Tax Expense | 15,347 | 10,007 | 15,406 | | Minority Interest |
-
|
-
|
-
| | | | Net Income From Continuing Ops | 28,353 | 17,478 | 24,610 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
| | Other Items |
-
|
-
|
-
| | | | Net Income | 28,353 | 17,478 | 24,610 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $28,353 | $17,478 | $24,610 |
|
0.34% Nasdaq 
0.16 (0.23%) 
Income Statement
